Quick Answer
Neuronetics, Inc. reported Research And Development Expense of $6.58 million for the year ending 2025.
- Neuronetics, Inc. showed a decrease of -48.4% in Research And Development Expense from 2024 to 2025.
- This data is from Neuronetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $2.03 million | Q2 2017: $2.15 million | Q3 2017: $1.84 million | Q4 2017: $1.92 million | Q1 2018: $1.56 million | Q2 2018: $2.33 million | Q3 2018: $2.13 million | Q4 2018: $2.22 million | Q1 2019: $2.79 million | Q2 2019: $3.22 million | Q3 2019: $3.49 million | Q4 2019: $4.25 million | Q1 2020: $3.02 million | Q2 2020: $2.12 million | Q3 2020: $1.95 million | Q4 2020: $2.11 million | Q1 2021: $2.31 million | Q2 2021: $2.29 million | Q3 2021: $1.58 million | Q1 2022: $1.80 million | Q2 2022: $2.05 million | Q3 2022: $2.35 million | Q1 2023: $2.79 million | Q2 2023: $2.36 million | Q3 2023: $2.16 million | Q1 2024: $2.35 million | Q2 2024: $2.24 million | Q3 2024: $2.42 million | Q1 2025: $1.62 million | Q2 2025: $1.80 million | Q3 2025: $1.50 million.
- Over the full 10 years of available data (2016 to 2025), Neuronetics, Inc.'s Research And Development Expense has declined by 19.9%.
- Historical annual values: Fiscal year 2025: $6.58 million | Fiscal year 2024: $12.77 million | Fiscal year 2023: $9.52 million | Fiscal year 2022: $9.34 million | Fiscal year 2021: $7.92 million | Fiscal year 2020: $9.20 million | Fiscal year 2019: $13.75 million | Fiscal year 2018: $8.23 million | Fiscal year 2017: $7.94 million | Fiscal year 2016: $8.22 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: